Is current smoking status and its relationship to anti-cyclic citrullinated peptide antibodies a predictor of worse response to biological therapies in rheumatoid arthritis patients?

Author(s):
Torrente-Segarra, V.; Bergstra, S.A.; Solomon-Escoto, K.; Silva, J.A.P.; Veale, D.J.; Al-Emadi, S.; Huizinga, T.W.J.
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-12-31
Language
English
Is part of
Scandinavian Journal of Rheumatology (2018), Vol. 47, no. 5, p. 360-363
hdl
1887/95757
doi
10.1080/03009742.2017.1418423